These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2201178)

  • 1. All patients with left ventricular systolic dysfunction should be treated with an angiotensin-converting enzyme inhibitor: a protagonist's viewpoint.
    Massie BM
    Am J Cardiol; 1990 Aug; 66(4):439-43. PubMed ID: 2201178
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial response to angiotensin-converting enzyme therapy in systolic heart failure.
    Dries DJ; Yancy CW; Strong MA; Drazner MH
    Congest Heart Fail; 2004; 10(1):30-3. PubMed ID: 14872155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors.
    Jolobe OM
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):115. PubMed ID: 7551489
    [No Abstract]   [Full Text] [Related]  

  • 5. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B
    Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
    Solomon SD; Skali H; Bourgoun M; Fang J; Ghali JK; Martelet M; Wojciechowski D; Ansmite B; Skards J; Laks T; Henry D; Packer M; Pfeffer MA;
    Am Heart J; 2005 Aug; 150(2):257-62. PubMed ID: 16086927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular remodeling and angiotensin-converting enzyme inhibitors.
    Goldstein S; Sabbah H
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S27-31. PubMed ID: 7700061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N
    J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC; Manoria P
    J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction.
    Bart BA; Gattis WA; Diem SJ; O'Connor CM
    Am J Cardiol; 1997 Apr; 79(8):1118-20. PubMed ID: 9114778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL; Ahmed A
    J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of angiotensin-converting enzyme inhibitors in congestive heart failure].
    Takeuchi K; Takeda T
    Nihon Rinsho; 1993 May; 51(5):1287-92. PubMed ID: 8331796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
    Sabatini T; Rozzini R; Trabucchi M
    Circulation; 2005 May; 111(17):e276-7; author reply e276-7. PubMed ID: 15867189
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.
    Abdulla J; Pogue J; Abildstrøm SZ; Køber L; Christensen E; Pfeffer MA; Yusuf S; Torp-Pedersen C
    Eur J Heart Fail; 2006 Jan; 8(1):90-6. PubMed ID: 16054435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE; McKinnie JJ; Greenberg SS; Giles TD
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 19. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators?
    Massie BM
    Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.